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TITLE OF CASE Do not include “a case report” 
Successful transcutaneous pacing following ventricular standstill during anaesthetic induction in a 
dog with third-degree atrioventricular block  
SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online) 
Third-degree atrioventricular block is a haemodynamically unstable bradyarrhythmia frequently 
resulting in symptoms of lethargy, weakness and collapse. In this reported case, a four-year-four-
month-old male neutered Cavalier King Charles spaniel diagnosed with third-degree 
atrioventricular block was referred for transvenous permanent pacemaker implantation. During 
induction of general anaesthesia the dog suffered cardiac arrest consistent with ventricular 
standstill, as indicated by cessation of ventricular electrical activity on the electrocardiogram 
monitor and the absence of a peripheral pulse. The prior placement of transthoracic pacing pads 
under sedation allowed for rapid commencement of temporary transcutaneous pacing and proved 
effective in achieving ventricular capture with re-establishment of cardiac output. The subsequent 
general anaesthesia for implantation of a permanent pacemaker was uneventful. This report 
considers the possible causes of ventricular escape rhythm suppression and highlights the 
importance of ensuring availability of a temporary pacing method from the outset when 
anaesthetising animals with unstable and symptomatic bradyarrhythmias. 
 
BACKGROUND Why you think this case is important – why did you write it up? 
 
Permanent pacemaker implantation is indicated in dogs with symptomatic bradyarrhythmias 
including high-grade second degree and third-degree atrioventricular (AV) block, sick sinus 
syndrome (SSS) and sinus arrest (1). Cardiac arrest during implantation of permanent pacemakers 
is an occasionally reported complication of the surgical procedure itself, occurring consequently 
to ventricular fibrillation (2,3). Often, exacerbation of bradyarrhythmias may be detected 
following induction of general anaesthesia in these dogs, with one retrospective study identifying 
a requirement for temporary transcutaneous pacing (TCP) in 27 out of 77 cases (4). Although no 
set guidelines currently exist for activation of temporary pacing of anaesthetised dogs undergoing 
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pacemaker implantation, consistent initiation has been reported in incidences of asystole or with a 
heart rate of less than 20-25 beats per minute (bpm) (4). Prolonged periods of unstable and 
infrequent ventricular escape rhythms can result in myocardial ischemia which can increase the 
risk of ventricular fibrillation (2). 
 
This case report documents an incidence of ventricular standstill on induction of general 
anaesthesia in a dog with third-degree AV block undergoing pacemaker implantation. When this 
occurred, the electrocardiogram (ECG) monitor showed cessation of the dog’s ventricular escape 
rhythm, resulting in the absence of cardiac output. While the exact cause of ventricular standstill 
could not be determined, the potential for both sedative and anaesthetic agents to exacerbate 
inherent haemodynamic instability must be considered. In this case, TCP proved to be lifesaving 
and this report aims to highlight the importance of ensuring availability of a temporary pacing 
method prior to anaesthetising dogs with third-degree AV block.  
 
CASE PRESENTATION Presenting features, clinical and environmental history 
A four-year-four-month old male neutered Cavalier King Charles Spaniel weighing 10.3 kg 
presented with a one-month history of lethargy and exercise intolerance, with two syncopal 
episodes during this period. On presentation, the dog had a heart rate of 32 bpm and strong 
synchronous pulses, with thoracic auscultation revealing a grade III/VI left systolic basal murmur. 
The dog had a regular respiratory pattern and a rate of 24 breaths per minute with no 
abnormalities detected on pulmonary auscultation. Mucous membranes were pink and moist with 
a capillary refill time of less than two seconds. Rectal temperature was 37.9 degrees Celsius.  
Identification of a pronounced bradycardia indicated a requirement for ECG analysis, which 
provided a diagnosis of third-degree AV block with an atrial rate of 144 bpm and ventricular 
escape rate of 36 bpm. Echocardiography revealed mild thickening of the mitral valve leaflets 
with regurgitation and visualisation of global cardiac dilation suspected to be secondary to 
chronic bradycardia. A mildly elevated platelet count of 528x10^9/L was the only abnormality on 
haematology and biochemistry results were all within reference range. The decision was taken to 
anaesthetise the dog for permanent transvenous pacemaker implantation. 
Following placement of a 22G intravenous catheter in the left cephalic vein, the dog was 
premedicated with 20 µg/kg acepromazine (Acecare 2 mg/ml; Animalcare, UK) and 20 µg/kg 
buprenorphine (Buprecare 0.3 mg/ml; Animalcare, UK) intravenously. After approximately 25 
minutes, sedation was adequate to enable clipping of both hemithoraces and the bilateral 
placement of paediatric pacing electrodes (EDGE System radiotransparent electrodes with QUIK-
COMBO connector, Physio-Control) between intercostal spaces 5-7 at the level of the heart apex, 
secured in place using non adhesive elasticated bandaging. Pacing leads from the transcutaneous 
pacing system (Lifepak-20; Medtronic, USA) were attached to the paediatric pacing electrodes 
and ECG leads were connected to ECG pads placed on the paw pads of the left and right forelimb 
and left hindlimb. Placement of a Doppler ultrasound probe over the left dorsal metatarsal arterial 
pulse allowed for continuous audible monitoring of the peripheral pulse and intermittent non-
invasive arterial blood pressure measurements. 
 
The dog was moved into theatre and general anaesthesia was induced with a total dose of 3.3 
mg/kg propofol (PropoFlo Plus 10 mg/ml; Zoetis, UK) intravenously administered to effect with 
the dog positioned in left lateral recumbency. The trachea was intubated with a cuffed 6.5 mm 
endotracheal tube (ETT). The ETT was connected to a circle breathing system and general 
anaesthesia maintained with sevoflurane vaporised in oxygen. Immediately following the period 
of general anaesthetic induction and tracheal intubation, the right femoral arterial pulse, which 
was being continuously monitored, became undetectable with simultaneous loss of the previously 
audible Doppler signal. On observation of the ECG trace it was noted that the third-degree AV 
block had converted to ventricular standstill, with only P waves visualised and complete loss of 
ventricular escape complexes. While P wave rate was not recorded, their frequency on the ECG 
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monitor was observed to decline in comparison to preinduction values. Although the animal 
maintained spontaneous respiration, the end tidal carbon dioxide values were observed to 
decrease on the capnograph trace from approximately 40 mmHg (5.4 kPa) to values < 30 mmHg 
(4.0 kPa), suggesting a sudden drop in cardiac output. 
 
INVESTIGATIONS If relevant 
 
 
 
 
 
 
 
 
DIFFERENTIAL DIAGNOSIS If relevant 
Absence of a peripheral pulse and cessation of ventricular escape complexes on the ECG resulted 
in a diagnosis of ventricular standstill. 
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TREATMENT If relevant  
Following detection of ventricular standstill, TCP was immediately initiated at a rate of 80 bpm. 
It is approximated that the time between loss of a peripheral pulse and commencement of TCP 
was no greater than 40 seconds in duration. The TCP current was incrementally increased until 
capture was observed, as indicated by the appearance of a wide QRS complex proceeding each 
pacing spike on the ECG monitor and the return of a palpable peripheral arterial pulse. As a result 
of temporary TCP causing generalised extraneous muscle contraction, 0.1 mg/kg atracurium 
(Atracurium besilate 10 mg/ml; Hameln Pharmaceuticals, UK) was administered intravenously to 
achieve neuromuscular blockade and prevent the associated movements. Volume controlled 
intermittent positive pressure ventilation (IPPV) was immediately started at a tidal volume of 110 
ml and respiratory rate of 12 breaths per minute.  
 
OUTCOME AND FOLLOW-UP   
General anaesthesia for implantation of the transvenous permanent pacemaker lasted for 150 
minutes in duration and was uneventful. Following exteriorisation of the right jugular vein, an 
incision into the vessel enabled introduction of a passive fixation permanent pacing lead into the 
apex of the right ventricle under fluoroscopic guidance. Whilst occasional ventricular premature 
complexes were observed on the ECG during presence of the permanent lead in the right 
ventricle, non-invasive mean arterial pressures were consistently maintained above 60 mmHg 
throughout general anaesthesia. 
  
Following endocardial lead placement, TCP was discontinued, resulting in heart rate dropping to 
30 bpm and recurrence of the dog’s intrinsic third-degree AV block. The permanent pacing lead 
was subsequently attached to a pulse generator set at 70 bpm and 3.5 volts to achieve capture. 
Following securement of the permanent pacing lead to the jugular vein, which was ligated 
cranially, a subcutaneous pocket was created in the right neck region for placement of the pulse 
generator. Transient detachment of the pacing lead from the generator allowed for its tunnelling 
under the skin and then subsequent reconnection. The pulse generator was placed within the 
subcutaneous pocket, with subcutaneous tissue and skin closure achieved with 2 metric 
poliglecaprone 25 (Monocryl; Ethicon) and 2 metric polydioxanone (PDS II; Ethilon) 
respectively. 
 
Recovery from general anaesthesia was smooth and the dog was taken to recover in the intensive 
care unit. In order to ensure the dog remained calm and to prevent the risk of pacing lead 
dislodgement, 20 µg/kg acepromazine was administered intravenously every 6 hours overnight. 
In addition, avoidance of neck lead usage and prevention of any blood sampling from the jugular 
veins was instructed. Although the surgery was deemed to be minimally invasive, 20 µg/kg 
buprenorphine was administered intravenously every 6 hours overnight for the purpose of 
analgesia provision. The dog was discharged from the hospital four days post operatively, with 
the period of rest during hospitalisation anticipated to allow for initial stabilisation of the pacing 
lead. During the period of hospitalisation, no additional complications were reported. 
 
DISCUSSION Include a very brief review of similar published cases  
Third-degree AV block is thought to most commonly occur as a result of a structural lesion 
within the cardiac conduction system but may also arise due to functional causes such as 
hyperkalemia or intoxication with calcium channel blockers (5,6,7). In a case series of four dogs 
with concurrent mitral valve endocardiosis, third-degree AV block was suggested to occur as a 
result of the altered haemodynamics causing mechanical damage to the myocardium and 
consequential fibrotic lesions developing within the AV conduction system (6). Third-degree AV 
block occurs with disturbance of conduction between the atria and ventricles, characterised on the 
ECG by P waves that are unassociated with QRS complexes. While the pacemaker cells of the 
sinoatrial node continue to depolarise and cause atrial contraction at a normal intrinsic rate, the 
absence of AV conduction results in development of a ventricular escape rhythm. Escape rhythms 
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originate due to the presence of slowly depolarizing subsidiary pacemaker cells within either the 
AV junction or the ventricles and are characterised by widened QRS complexes occurring 
independently of P wave activity (8). Symptoms of third-degree AV block occur as a result of 
reduction in cardiac output, a product of heart rate and stroke volume, and typically include 
lethargy, weakness and collapse (9). In consideration that many dogs with third-degree AV block 
are at high risk of sudden death, permanent pacemaker implantation is the treatment of choice in 
cases where the cause is idiopathic or untreatable (9). 
 
In this reported case, the dog presented outside of working hours with a symptomatic bradycardia 
and transthoracic pacing pads were placed as a precaution in case of haemodynamic instability 
under general anaesthesia. One retrospective study by Ward et al. (10) reviewing the medical 
records of 97 dogs undergoing permanent transvenous pacemaker implantation identified 
significantly more major complications with procedures occurring out of hours, although this was 
attributed to differences in personnel factors rather than provision of temporary pacing. While the 
use of TCP in dogs undergoing pacemaker implantation has previously been associated with 
reductions in long term survival, those requiring external pacing may represent the proportion of a 
population initially presenting with more severe disease and greater haemodynamic instability 
(11).  
 
Placement of transthoracic pacing pads to the hemi thoraces was in this case facilitated following 
sedation of the dog with buprenorphine and acepromazine, the latter of which was selected for its 
anxiolytic effect and long duration of action. The vasodilatory effects of acepromazine can 
additionally be beneficial in reducing afterload in cases of degenerative mitral valve disease, a 
comorbidity frequently identified in dogs requiring permanent pacemaker implantation (12, 13). 
Buprenorphine, a partial mu agonist opioid, was selected preferentially in this reported case over 
a full mu agonist opioid in an attempt to maintain heart rate and because permanent pacemaker 
implantation via a transvenous approach was deemed to be minimally invasive surgery (14, 15). 
Alternative opioids which could be considered are butorphanol or pethidine. Unlike other full mu 
agonist opioids, pethidine has anticholinergic effects that maintain heart rate (16). 
Buprenorphine’s longer duration of action compared to butorphanol and pethidine provided the 
advantage of enhancing the sedative effects of acepromazine, while also ensuring analgesia 
provision for the duration of surgery and negating the requirement for repeated administrations 
intraoperatively.  
 
Detection of ventricular standstill following anaesthetic induction prompted immediate 
commencement of TCP. While it is difficult to ascertain the cause of ventricular escape rhythm 
cessation, the potential contributing effects of both the premedicant agents and propofol must be 
considered in this case. Previously, acepromazine has been identified to provide some protection 
against ventricular arrhythmias in halothane anaesthetised dogs receiving epinephrine infusions 
(17, 18). The anti-arrhythmic properties of acepromazine have been attributed to a number of 
possible mechanisms, including stabilisation of the resting membrane potential in cardiac 
myocytes (17, 19) and antagonism of alpha 1 adrenoreceptors within the myocardium (18). 
Acepromazine can additionally cause a vagally meditated bradycardia, although typically at doses 
higher than those used in clinical practice (20). Alternatively, buprenorphine administration can 
result in a vagally mediated bradycardia, with acetylcholine stimulating reductions in the rate of 
spontaneous depolarisation of the sinoatrial node and subsidiary pacemaker cells (12). 
 
In consideration that ventricular standstill was identified following anaesthetic induction, it is 
possible that propofol exerted a suppressive effect on ventricular depolarisation. Propofol can 
cause bradycardia, albeit via a different mechanism to that of acepromazine and buprenorphine, 
with suppression of the funny current responsible for the initial depolarization of pacemaker cells 
being one proposed mechanism of action (21). Alternative options for induction of general 
anaesthesia in this case could have included etomidate or ketamine, in combination with a 
benzodiazepine. Etomidate is considered to be the anaesthetic induction agent with the least 
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cardiovascular depressant effects, although it can induce vomiting, excitation and myoclonus 
(22). The use of ketamine has been described in the anaesthetic management of dogs undergoing 
pacemaker implantation (23). Ketamine has sympathomimetic effects but it can also have direct 
negative inotropic effects, particularly in patients with catecholamine depletion (24). 
Administration of propofol in this case may have exacerbated the pre-existing haemodynamic 
instability in this dog and contributed to ventricular standstill.  
 
The requirement to initiate TCP in dogs with third-degree AV block following detection of 
asystole or profound bradycardia during pacemaker implantation is not uncommon (4,11). The 
Reassessment Campaign on Veterinary Resuscitation (RECOVER) guidelines recommend basic 
life support (BLS), consisting of airway management, manual ventilation and chest compressions, 
following detection of asystole (25). When arrest is suspected to be of primary cardiac origin, 
restoration of circulation should be prioritised in order to maintain coronary and cerebral 
perfusion (25). In comparison to external chest compressions, which passively expel blood from 
the heart, external pacing methods result in electromechanical capture of the ventricles and have 
been shown to result in increased cardiac output (26,27). In human medicine, pacing is 
recommended on detection of asystole if the patient is known to have high-grade second or third-
degree AV block and when P waves are still visualised on the ECG (28). The practicality of 
preparing and initiating temporary pacing has been acknowledged as a possible cause of delay in 
restoring circulation and should be considered (29). In this case, placement of pacing pads prior to 
anaesthetic induction enabled pacing to commence almost immediately following loss of a 
ventricular escape rhythm and demonstrates the importance of having a temporary pacing 
modality when anaesthetising dogs with third-degree AV block. 
In this case, TCP was effective in restoring cardiac output and administration of positive 
chronotropic drugs as part of advanced life support (ALS) was not considered necessary. One 
retrospective study of 77 dogs presenting for pacemaker implantation identified that only 5% 
were observed to be atropine responsive on initial presentation, demonstrating the unpredictable 
effects of anticholinergics in situations of cardiac conduction system disturbances (10). Despite 
the low percentage of atropine responsive dogs, Ward et al (10) reported pre-emptive 
administration of anticholinergics to all dogs prior to anaesthesia for pacemaker implantation, in 
efforts to avoid vagally mediated reductions in ventricular response rate associated with opioid 
administration and general anaesthesia. Interestingly, depending on the location of subsidiary 
pacemaker cells, atropine may result in an increase in the rate of ventricular escape rhythms (9). 
When anaesthetising dogs with third-degree AV block, atropine should not be relied upon to 
avoid cardiac arrest; An appropriate and effective means of temporary pacing must be in place. 
 
First introduced for humans in the 1950’s, TCP provided a non-invasive alternative to temporary 
transvenous pacing (TVP) and hence removed the risks of haemorrhage, infection and 
arrhythmias occasionally reported with the latter (30, 31, 32). The predominant difficulty 
surrounding the use of temporary TVP in clinical practice however is the time and expertise 
required for placement; the temporary pacing lead must be guided into the right ventricle via a 
saphenous or femoral vein, the practicalities of which may be challenging in smaller patients (33). 
Placement of a temporary TVP lead into the right ventricle is enhanced by visualisation of the 
pacing lead under fluoroscopic guidance but this imaging technique may not always be readily 
available and increases radiation exposure to personnel. Provided that the pacing pads are placed 
correctly and a suitable current and pacing rate is applied, TCP offers a quickly accessible 
alternative to TVP and may be a more appropriate option in emergency situations when time is 
critical.  
 
A requirement for TCP to treat asystole or profound bradycardia is commonplace in dogs 
undergoing general anaesthesia for permanent pacemaker implantation (4, 23), demonstrating the 
importance of access to a temporary pacing method in symptomatic bradyarrhythmic animals. 
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Effective approaches to TCP have previously been well described in the veterinary literature (4, 
30). The predominant disadvantage of TCP when compared to TVP is the requirement for greater 
currents in order to achieve ventricular capture, which can result in significant extraneous muscle 
contractions. Muscle contractions caused by TCP are reported to be painful, necessitating 
appropriate analgesic provision. When such pacing is performed on an elective rather than 
emergent basis, it should not be done so in the conscious animal. Techniques such as positioning 
the negative anode on the left hemithorax and ensuring electrodes are positioned at the level of 
the heart apex may assist in achieving the lowest effective current for capture, but any movement 
under general anaesthesia is undesirable for surgery (15, 34). The skeletal muscle contractions 
induced from TCP under general anaesthesia can result in inability to provide effective IPPV and 
can therefore risk hypoxaemia (35). Administration of neuromuscular blocking agents e.g. 
atracurium, can abolish TCP induced skeletal muscle contraction but will consequently result in a 
requirement for IPPV provision due to concurrent blockade of the respiratory muscles. 
Administration of neuromuscular blocking agents requires careful monitoring, ideally with the 
use of a peripheral nerve stimulator, as postoperative residual block in recovery can result in 
upper respiratory obstruction and impaired ventilation (36, 37). 
 
This reported case demonstrates the importance of having a method to instigate temporary cardiac 
pacing available prior to anaesthetising animals with unstable and symptomatic bradyarrhythmias. 
Dogs with third-degree AV block are haemodynamically unstable and the cardiovascular effects 
of both sedative and anaesthetic agents should be considered prior to their administration. The 
value of ongoing monitoring in both the sedated and anaesthetised animal should not be 
underestimated and the use of Doppler and regular peripheral pulse palpation will greatly 
facilitate the rapid detection of asystole. TCP provides a non-invasive and rapid approach to 
treating asystole in animals with third-degree AV block, although an understanding of temporary 
pacemaker settings and neuromuscular blocking agents is additionally necessary for its effective 
and safe use.  
 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field 
Availability of a method of temporary cardiac pacing and familiarity with its use is critical when 
anaesthetising any dog with a bradyarrhythmia, particularly in unstable and symptomatic cases. 
 
The cardiac depressant effects of premedicant and anaesthetic induction agents may exacerbate 
pre-existing haemodynamic instability in dogs with third-degree AV block. 
 
Induction of general anaesthesia in bradyarrhythmic dogs warrants continuous monitoring of a 
peripheral pulse in order to quickly recognise and treat asystole should it occur. 
 
Effective and safe use of temporary transcutaneous pacing requires appropriate positioning of 
electrode pads and application of suitable pacing settings to achieve capture.  
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